| Home > Publications database > Emerging Role of Circulating Cell-Free RNA as a Non-Invasive Biomarker for Hepatocellular Carcinoma. |
| Journal Article (Review Article) | DKFZ-2024-01134 |
; ; ; ; ; ; ;
2024
Elsevier Science
Amsterdam [u.a.]
This record in other databases:

Please use a persistent id in citations: doi:10.1016/j.critrevonc.2024.104391
Abstract: Hepatocellular carcinoma (HCC) is a severe neoplastic disease associated with high morbidity and mortality rates. HCC is often detected at advanced stages leading to ineffective curative treatments. Recently, liquid biopsy has emerged as a non-invasive method to identify highly specific HCC biomarkers in bodily fluids such as blood, serum, urine, and saliva. Circulating cell-free nucleic acids (cfNAs), particularly cell-free DNA (cfDNA) and cell-free RNA (cfRNA), have become promising candidates for biomarkers in liquid biopsy applications. While cfDNA presented significant challenges, researchers have turned their attention to cfRNA, which can be efficiently identified through various methods and is considered a potential biomarker for cancer diagnosis and prognosis. This review primarily focuses on studies related to detecting various cfRNA in body fluids as biomarkers. The aim is to provide a summary of available information to assist researchers in their investigations and the development of new diagnostic and prognostic tools.
Keyword(s): Biomarker ; Diagnostic ; Hepatocellular carcinoma ; Liquid biopsy ; Prognostic ; cell-free RNA
|
The record appears in these collections: |